Clinical Trials Browser

Phase 1/2 × Daclizumab × Clear all

Lymphoma, Radiation Injuries, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00001941 2012-08-20

Anti-Tac for Treatment of Leukemia

Phase 1/2 Completed

34 enrolled 12 charts

LymphoidOther hematologic neoplasm

Diabetes Mellitus, Insulin-Dependent, 10, Leukemia, T-Cell, Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections

NCT00002681 2011-06-10

Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma

Phase 1/2 Completed

25 enrolled

LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00847106 2009-02-19

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients

Phase 1/2 Completed

15 enrolled

Dermatologic

Melanoma

Clinical Trials

Monoclonal Antibody Therapy in Treating Patients With Leukemia

Anti-Tac for Treatment of Leukemia

Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients